Clinical trial data and the FDA label are good sources for understanding benefits and risks
A GLP-1 weight loss plateau is a period when weight loss slows or temporarily stops during treatment, even though the medication may still be helping with appetite, food noise, portion control, and metabolic health
Why this matters: This clinical breakthrough demonstrates that a diabetes treatment can do more than manage blood sugarit can protect vital organs, reduce complications, and extend life expectancy
8 However, its underlying pathogenic mechanisms remain incompletely understood
Both Semaglutide and Tirzepatide are part of a group of meds called GLP-1 receptor agonists
Wegovy works primarily through hormonal signaling in the brain and gut, while berberine works at a cellular level by activating metabolic enzymes